Erratum: HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients (Experimental and Clinical Endocrinology and Diabetes (2007) 115, (124-129) DOI: 10.1055/s-2007-949589));HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 2, 2007, Pages 124-129

  Katarina, K ^a   Daniela, P ^a   Peter, N ^a   Marianna, R ^a   Pavlina, C ^a   Stepanka, P ^a   Jan, L ^a   Ludmila, T ^a   Michal, A ^a   Marie, C ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

HLA; LADA; NFKB1; NFKBIA; T1DM

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 33947101012     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-949589     Document Type: Erratum

References (29)

1. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11: 191-198
2. Baldwin AS Jr.: Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001; 107: 3-6
3. Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071
4. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Hating HU, Schleicher E, Nawroth PP: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001; 50: 2792-2808
5. Borm ME, van Bodegraven AA, Mulder CJ, Kraal C, Bouma G: A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet 2005; 32: 401-405
6. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11: 183-190
7. Cerna M, Novota P, Kolostova K, Cejkova P, Zdarsky E, Novakova D, Kucera P, Novak J, Andel M: HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes. Eur J Immunogenet 2003; 30: 401-407
8. Chen F: Is NF-kappaB a culprit in type 2 diabetes? Biochem Biophys Res Commun 2005; 332: 1-3
9. Cinek O, Kolouskova S, Snajderova M, Sumnik Z, Sedlakova P, Drevinek P, Vavrinec J, Ronningen KS: HLA class II genetic association of type 1 diabetes mellitus in Czech children. Pediatr Diabetes 2001; 2: 98-102
10. Csorba TR, Lyon AW: Abnormal proinsulin congeners as autoantigens that initiate the pathogenesis of Type 1 diabetes. Med Hypotheses 2005; 64: 186-191
11. Curran JE, Weinstein SR, Griffiths LR: Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 2002; 188: 103-107
12. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 599-622
13. Gylvin T, Bergholdt R, Nerup J, Pociot F: Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families. Genes Immun 2002; 3: 430-432
14. Haslbeck KM, Schleicher E, Bierhaus A, Nawroth P, Haslbeck M, Neundorfer B, Heuss D: The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT). Exp Clin Endocrinol Diabetes 2005; 113: 288-291
15. Hayden MS, Ghosh S: Signaling to NF-kappaB. Genes Dev 2004; 18: 2195-2224
16. Hegazy DM, O'Reilly DA, Yang BM, Hodgkinson AD, Millward BA, Demaine AG: NFkappaB polymorphisms and susceptibility to type 1 diabetes. Genes Immun 2001; 2: 304-308
17. Heron E, Deloukas P, van Loon AP: The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction. Genomics 1995; 30: 493-505
18. Jaini R, Kaur G, Mehra NK: Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population. Hum Immunol 2002; 63: 24-29
19. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar JP, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR: Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004; 13: 35-45
20. Lechler RI, Norcross MA, Germain RN: Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells. J Immunol 1985; 135: 2914-2922
21. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
22. Novota P, Cerna M, Kolostova K, Cejkova P, Zdarsky E, Novakova D, Kucera P, Novak J, Andel M: Diabetes mellitus in adults: association of HLA DRB1 and DQB1 diabetes risk alleles with GADab presence and C-peptide secretion. Immunol Lett 2004; 95: 229-232
23. Ota N, Nakajima T, Shirai Y, Emi M: Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit 1 (NFKB1) locus. J Hum Genet 1999; 44: 129-130
24. Rewers A, Babu S, Wang TB, Bugawan TL, Barriga K, Eisenbarth GS, Erlich HA: Ethnic differences in the associations between the HLA-DRB1*04 subtypes and type 1 diabetes. Ann N Y Acad Sci 2003; 1005: 301-309
25. Rueda B, Lopez-Nevot MA, Ruiz MP, Ortega E, Maldonado J, Lopez M, Martin J: CA microsatellite polymorphism of the nuclear factor kappa B1 gene in celiac disease. Eur J Immunogenet 2004; 31: 129-132
26. Shawkatova I, Fazekasova H, Michalkova D, Martinka E: Association of type I diabetes mellitus with HLA alleles]. Bratisl Lek Listy 2000; 101: 624-625
27. Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD, Hulme JS, Vella A, Dahlman I, Lam AC, Nutland S, Walker NM, Twells RC, Todd JA: Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet 2006; 7: 20
28. Wheat W, Kupfer R, Gutches DG, Rayat GR, Beilke J, Scheinman RI, Wegmann DR: Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur J Immunol 2004; 34: 1395-1404
29. World Health Organization Definition Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva, Switzerland: Department of Noncommunicable Disease Surveillance. WHO, 1999